US Drug Recall Register
Class II · Moderate risk Completed Initiated Jan 17, 2024 (3 years ago)

Adrenalin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.

What was recalled

Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80 Summit View Lane, Bastian, VA 24314, Original NDC 42023-159-25 Repack NDC 0404-9810-01

Recalling firm
Henry Schein Inc. and Glove Club HSI Gloves Inc.
NDC code
42023-159-25
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0342-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Epinephrine recalls

See all
Class III · Low risk Ongoing

Epinephrine Injection

Reason Failed Impurities/Degradations Specifications

Fresenius Kabi USA, LLC NDC 63323-696-02 D-0581-2026
Class II · Moderate risk Ongoing

EPINEPHRINE Injection

Reason Lack of Assurance of Sterility

International Medication Systems Ltd. NDC 76329-3318-1 D-0483-2026
Class II · Moderate risk Ongoing

norepinephrine Bitartrate

Reason Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services NDC 71266-5027-02 D-0439-2026
Class II · Moderate risk Ongoing

norepinephrine Bitartrate

Reason Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Fagron Compounding Services NDC 71266-5026-02 D-0438-2026
Class II · Moderate risk Ongoing

Maximum

Reason Stability Data Does Not Support Expiry Date.

HTO Nevada Inc. dba Kirkman D-0387-2026